Skip to main content
. 2016 Oct 17;6:35514. doi: 10.1038/srep35514

Table 2. Changes in corrected volume and susceptibility (referenced to CSF) between controls and MCI.

  Corrected volume (ml) Mean ± STE χ (ppb) Mean ± STE
Controls MCI Controls MCI
Amygdala 4.03 ± 0.09 3.60 ± 0.15*** −16.6 ± 2.3 −17.4 ± 2.3
Nucleus Acc 1.76 ± 0.07 1.84 ± 0.10 11.8 ± 3.7 11.8 ± 5.5
Hippocampus 8.62 ± 0.18 7.55 ± 0.22*** −1.3 ± 1.7 −0.6 ± 2.9
Entorhinal Ctx 2.15 ± 0.13 2.01 ± 0.15 23.4 ± 3.8 25.8 ± 3.3
Thalamus 13.88 ± 0.19 12.83 ± 0.40*** −7.7 ± 1.8 −8.9 ± 1.8
Caudate Nucleus 9.53 ± 0.24 9.31 ± 0.30 41.4 ± 4.2 38.2 ± 3.7
Putamen 10.11 ± 0.27 8.92 ± 0.43*** 63.6 ± 4.4 61.2 ± 4.3
Globus Pallidus 3.50 ± 0.07 3.35 ± 0.09 104.5 ± 4.9 99.3 ± 5.0
Frontal Ctx 16.56 ± 1.98 16.13 ± 2.36 2.1 ± 1.8 2.6 ± 2.2
Temporal Ctx 23.24 ± 2.40 22.13 ± 2.77 0.3 ± 1.6 2.1 ± 2.1
Parietal Ctx 21.63 ± 1.13 21.23 ± 1.32 4.3 ± 1.6 4.0 ± 1.8
Occipital Ctx 18.76 ± 2.51 18.38 ± 2.93 3.6 ± 1.8 3.8 ± 2.1

Ctx = Cortex. Data are presented as mean ± standard error (STE). ***Significant difference between controls and MCI with p < 0.001.